These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1619498)

  • 1. What to treat? The structural basis for renal and vascular complications and hypertension, and the role of angiotensin converting enzyme inhibition. Symposium, 26th meeting of the European Association for the Study of Diabetes. Dublin, Ireland, 10 September 1991.
    J Hypertens Suppl; 1992 Apr; 10(1):S1-53. PubMed ID: 1619498
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
    Studney D
    Can J Cardiol; 2002 May; 18 Suppl A():3A-6A. PubMed ID: 12045787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What is a good marker for better antihypertensive therapy in diabetic patients when coexisting with hypertension].
    Eguchi K; Kario K; Shimada K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():679-84. PubMed ID: 12387069
    [No Abstract]   [Full Text] [Related]  

  • 5. The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.
    Ruilope L; Kjeldsen SE; de la Sierra A; Mancia G; Ruggenenti P; Stergiou GS; Bakris GL; Giles TD
    Blood Press; 2007; 16(2):72-9. PubMed ID: 17612904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiotensin converting enzyme inhibitors or angiotensin II receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us?].
    Krzesinski JM; Montrieux Ch; Scheen AJ
    Rev Med Liege; 2006; 61(5-6):414-22. PubMed ID: 16910270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARBs for cardiovascular and renal protection in high-risk patients.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):224. PubMed ID: 21881697
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent review highlights implications for prevention of cardiovascular disease.
    Cardiovasc J S Afr; 2003; 14(3):161-2. PubMed ID: 12931737
    [No Abstract]   [Full Text] [Related]  

  • 9. Slowing progression along the renal disease continuum.
    Kopyt NP
    J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition in cardiovascular disease.
    Francis GS
    N Engl J Med; 2000 Jan; 342(3):201-2. PubMed ID: 10639547
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus.
    Webster J; Murchison LE; Robb OJ
    Scott Med J; 1988 Apr; 33(2):247-8. PubMed ID: 2840738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system blockade and cardiovascular and renal protection.
    Hoogwerf BJ
    Am J Cardiol; 2010 Jan; 105(1 Suppl):30A-5A. PubMed ID: 20102971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of CVD in patients with CKD].
    Nishimoto-Hazuku A; Node K
    Nihon Rinsho; 2008 Sep; 66(9):1741-5. PubMed ID: 18788404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease.
    McFarlane SI; Kumar A; Sowers JR
    Am J Cardiol; 2003 Jun; 91(12A):30H-37H. PubMed ID: 12818733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal complications of diabetes.
    Min TZ; Stephens MW; Kumar P; Chudleigh RA
    Br Med Bull; 2012; 104():113-27. PubMed ID: 23118262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
    Karalliedde J; Viberti G
    J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should all patients with diabetes mellitus receive angiotensin-converting enzyme inhibitors?
    Eledrisi MS
    Endocr Pract; 2005; 11(3):209. PubMed ID: 16239212
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angiotensin converting enzyme inhibitors in arterial hypertension].
    Ramón González-Juanatey J
    Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiotensin converting enzyme inhibitors in prevention and treatment of vascular complications of diabetes].
    Ametov AS; Demidova TIu; Galieva OR
    Kardiologiia; 2005; 45(11):109-12. PubMed ID: 16353074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.